HRES 449
104th Congress
House
Health
Artificial implants
Autoimmune diseases
Breast cancer
Commerce
Education
Educational policy
Government Operations and Politics
Government paperwork
Health education
Joint diseases
Product safety
Women
Women's health
Relating to breast implants, the Food and Drug Administration, and breast care.
Introduced: June 6, 1996
See on congress.gov
Everywhere this bill has been
4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 14, 1996
Referred to the Subcommittee on Health and Environment.
Jun 7, 1996
Sponsor introductory remarks on measure. (CR E1032-1033)
Jun 6, 1996
Referred to the House Committee on Commerce.
Jun 6, 1996
Introduced in House
Plain-English summary
Expresses the sense of the House of Representatives that: (1) the Food and Drug Administration should issue a definitive statement on the relationship (or lack thereof) between silicone gel breast implants and connective tissue disease, classic auto-immune symptoms, and other serious diseases; and (2) the Food and Drug Administration and the National Cancer Institute should develop recommendations for breast care for women with breast implants.
What's happening now
Referred to the Subcommittee on Health and Environment.
Committees of jurisdiction
2
Cosponsors
1